sulfadiazine has been researched along with Blood Protein Disorders in 1 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
Blood Protein Disorders: Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lerner, G | 1 |
| Tarasidis, GC | 1 |
| Jenney, FS | 1 |
1 other study available for sulfadiazine and Blood Protein Disorders
| Article | Year |
|---|---|
Nocardiosis: the importance of early diagnosis and treatment.
Topics: Blood Protein Disorders; Diagnosis, Differential; Humans; Lung Diseases; Male; Middle Aged; Nocardia | 1967 |